1933 Industries Inc (CSE:TGIF) (OTCMKTS:TGIFF) told investors on Tuesday that it has begun transferring cannabis plants to its new cultivation centre in Las Vegas.
The new facility allows the Vancouver-based company to cultivate five times the amount of cannabis flower than was previously produced through its Alternative Medicine Association (AMA) line.
Research and development company OG DNA Genetics, which looks at cannabis genetics, will work out of the new facility as AMA’s partner in Nevada and provide expertise to develop a consistent phenotype strain for a new line of co-branded flower and pre-rolls.
READ: 1933 Industries transforms into multi-state operator after new agreement launches the brand in California
"We have constructed a one-of-a-kind, purpose-built facility, integrated with the latest technology to increase yields, bolster plant health and assure the consistency and quality of our products", said Chris Rebentisch, CEO at 1933.
"As experienced cultivators, we understand that controlling the growing environment is the most important part of cultivating high-quality craft cannabis at scale, which is why we spent significant time, capital and management's time to build a state-of-the-art indoor facility.”
Rebentisch also said that the cannabis company is investing in assets that will provide a continuous supply of the raw materials necessary to produce premium cannabis products and improve margins.
Once the transfer is complete, the plants will vegetate in the Vegas facility for nearly four weeks before the flower cycle begins, 1933 told investors in a statement. The flower cycle is expected to take an additional eight weeks before harvesting, drying, packaging and third-party testing begins.
The entire cycle will last around 16 weeks.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas